• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1070275-48
Device Problems Material Separation (1562); Failure to Advance (2524); Difficult to Advance (2920); Material Deformation (2976)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/14/2020
Event Type  Injury  
Manufacturer Narrative
The device is expected to be returned for evaluation.It has not yet been received.A follow up report will be submitted with all additional relevant information.The xience xpedition 48 is currently not commercially available in the us; however, it is similar to a device sold in the us.
 
Event Description
It was reported that the procedure was to treat a narrow lesion located in the left anterior descending coronary artery that was both heavily calcified and tortuous and 70% stenosed.The lesion was pre-dilated with a traveler balloon.A xience xpedition 48 stent delivery system (sds) was advanced against resistance to the lesion and once deployed, it was noted that the stent struts were flared, and the shaft separated into 2 pieces.The sds was then successfully removed from the body via a snare device.Two xience sierra stents were implanted, possibly to treat the flared stent struts and an nc traveler was used for post-dilatation.There was no reported adverse patient sequela and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported material separation was confirmed.The reported material deformation was not confirmed as there was no damage noted to the stent implant.The reported difficult to advance and failure to advance were unable to be replicated in a testing environment as they were based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that resistance was met with the narrow, heavily calcified, tortuous and 70% stenosed anatomy resulting in the reported difficult to advance and failure to advance.Manipulation of the device ultimately resulted in the reported material separation.There is no indication of a product quality issue with respect to manufacture, design or labeling.: reported details serial number date of implant - stent was not implanted device code (b)(4) - removed.
 
Event Description
Subsequent to the initial 30-day medwatch report, the following information was received: the xience xpedition 48 stent failed to reach the lesion and was not implanted as previously reported; however, there was a proximal shaft separation that required snaring to be removed from the anatomy.Once removed from the anatomy, the struts of the stent were noted to be flared.Two xience sierra stents were implanted to treat the lesion.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10027320
MDR Text Key189982378
Report Number2024168-2020-04127
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 06/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/05/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/04/2022
Device Catalogue Number1070275-48
Device Lot Number9012941
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/06/2020
Date Manufacturer Received05/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
Patient Weight53
-
-